Andrea Abbona

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 12, 2026
Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells.

|May 11, 2024
Effects of a Personalized Diet on Nutritional Status and Renal Function Outcome in Nephrectomized Patients with Renal Cancer.

Francesco Trevisani, Fabiana Laurenti, Francesco Fiorio

|Nov 14, 2023
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro

|Feb 28, 2023
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella

|Nov 26, 2022
The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience.

Nerina Denaro, Cinzia Solinas, Ornella Garrone

|Aug 26, 2022
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.

Marco Carlo Merlano, Nerina Denaro, Danilo Galizia

Pageof 2

Frequent Collaborators

6 joint publications

Matteo Paccagnella

6 joint publications

Ornella Garrone

5 joint publications

Marco Merlano

4 joint publications

Nerina Denaro